Asthma Inhaler Device Market: How Is the Asthma Inhaler Carbon Footprint Debate Reshaping Prescribing Patterns and Commercial Market Share?
Inhaler carbon footprint's commercial prescribing pattern disruption — the publication of life cycle assessment studies demonstrating that a single pMDI produces approximately twenty times the carbon dioxide equivalent greenhouse gas emissions of a comparable DPI or soft mist inhaler — with the NHS England committing to achieve net-zero carbon emissions by 2040 and explicitly...
0 Comments 0 Shares 14 Views 0 Reviews
Sponsored